Xin Lang Cai Jing·2026-02-13 10:07Group 1 - The article emphasizes the importance of financial support in overcoming the industrialization bottlenecks of "bottleneck" technologies in the biotechnology sector, aligning with the national innovation-driven development strategy and the demand for high-quality development in the future biotechnology industry [1] - Beijing Dingchi Biotechnology Co., Ltd. is highlighted as a leading enterprise in the upstream core consumables and innovative animal health sectors of domestic biopharmaceuticals, focusing on serum-free cell culture systems and key technologies for genetically engineered vaccines [1] - The urgent need for self-controlled key raw materials in biopharmaceuticals and the expanding market scale of innovative animal health indicate significant growth potential for the industry amid the wave of domestic substitution [1] Group 2 - China CITIC Bank Beijing Branch is noted for its commitment to the national innovation-driven development strategy, breaking away from traditional credit thinking that emphasizes collateral and past performance [2] - The bank has introduced a technology achievement transformation loan product, creating a specialized evaluation system focused on technological barriers, R&D strength, and market potential, aimed at providing precise "patient capital" for new productive forces [2] - CITIC Bank has provided 10 million yuan in critical financing support to Dingchi Biotechnology, facilitating financial services to earlier-stage, smaller, and more robust biotechnology enterprises, thereby supporting the domestic production of core biopharmaceutical consumables and the upgrade of the innovative animal health industry [2]